Investigation: GPs cite lack of expertise or funding as key factors in withdrawals of trans patients’ prescriptions. Billie ...

The global hormone replacement therapy market size was US$ 32.1 billion in 2021. The global hormone replacement therapy market is forecast to grow to US$ 51.1 billion by 2030 by growing at a compound ...

Er-Kim has extended its exclusive agreement with Ascendis Pharma, broadening the reach of three endocrinology treatments ...

The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and ...

Pfizer's PATINA trial highlights IBRANCE's potential in HR+/HER2+ metastatic breast cancer, improving outcomes with a ...

An experimental drug stops advanced breast cancer from progressing in some people with tumors that have grown resistant to ...

When a woman learns she has breast cancer , her reaction is often: take it out. Now doctors say that might not always be ...

Up to one in 10 pregnancies in the developed world are affected by placental growth restriction, and twice that in the ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The American Diabetes Association (ADA) urged healthcare ...

The FDA has accepted the NDA for paltusotine for the treatment and long-term maintenance of acromegaly in adults.

The market for endometriosis treatment is projected to attain a value of US$ 3.1 billion by 2034. According to Transparency ...